Aaron Koenig

Chief Medical Officer at Syndeio Biosciences

Role: Chief Medical Officer at Syndeio Biosciences
Location: Boston, MA, US
LinkedIn followers: 500 followers

Healthcare & Human ServicesView LinkedIn profile

Experience

Chief Medical Officer
Syndeio Biosciences
Nov 2025 — Present

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@syndeio.bio
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Syndeio Biosciences

Biotechnology Research · 21 employees · Founded 2025 · Indianapolis, Indiana, United States

Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform.

syndeio.bio

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.